Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mansoor R. Mirza(Copenhagen University Hospital), Ursula A. Matulonis(Dana-Farber Cancer Institute), Per Rosenberg(Nordic Society of Gynecologic Oncology), Radosław Mądry(Nordic Society of Gynecologic Oncology), Bradley J. Monk(Florida Cancer Specialists & Research Institute), Noa Ben-Baruch(Kaplan Medical Center), René dePont Christensen(University of Southern Denmark), Jonathan S. Berek(Stanford Health Care), Christian Marth(Nordic Society of Gynecologic Oncology), John Balser(Nordic Society of Gynecologic Oncology), Sven Mahner(Nordic Society of Gynecologic Oncology), Benedict B. Benigno(Northside Hospital), Ignace Vergote(KU Leuven), Domenica Lorusso(Agostino Gemelli University Polyclinic), Lucy Gilbert(McGill University Health Centre), Anne Dørum(Oslo University Hospital), Amit M. Oza(Ontario Institute for Cancer Research), Joseph Buscema(Nordic Society of Gynecologic Oncology), Anna V. Tinker(BC Cancer Agency), Jonathan A. Ledermann(London Cancer), Andrés Redondo(Hospital Universitario La Paz), B.J. Rimel(Cedars-Sinai Medical Center), Michel Fabbro(Nordic Society of Gynecologic Oncology), Shefali Agarwal(Nordic Society of Gynecologic Oncology), Philippe Follana(Nordic Society of Gynecologic Oncology), Jørn Herrstedt(Zealand University Hospital), Andreas du Bois(Nordic Society of Gynecologic Oncology), Antonio González-Martı́n(Spanish Ovarian Cancer Research Group)
New England Journal of Medicine
October 8, 2016
Cited by 2,453


Related Papers